30,980 Alzheimer's and dementia studies in plain English, each scored out of 100.
Use of systemic antibiotics is prevalent in the treatment of patients with end-stage dementia, despite the limited utility and discomfort associated with the use of these agents. 3 key findings →
Participants: 279 Evidence: low
Full summary, score breakdown and related studies → Original source
Prostate cancer (PCa) is one of the most prevalent malignancies affecting males worldwide. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Dementia patients frequently die after a pneumonia or prolonged intake problems. 2 key findings →
Participants: 166 Evidence: low
Full summary, score breakdown and related studies → Original source
A total of 41 articles met the eligibility criteria. 5 key findings →
Participants: 41 Evidence: low
Full summary, score breakdown and related studies → Original source
Community-dwelling elders' preferences for end-of-life care are not consistent with documentation in their medical records. 1 key finding →
Participants: 245 Evidence: low
Full summary, score breakdown and related studies → Original source
Educational programs may be useful in reducing racial differences in attitudes towards ACP. 2 key findings →
Design: cross-sectional Evidence: low
Full summary, score breakdown and related studies → Original source
Key mechanisms of action were: improved observation and awareness of residents, collaborative assessment, comprehensive 'picture of the person', systematic record keeping, improved review and monitoring, care planning and changes to care provision, and facilitated multi-agency communication. 1 key finding →
Evidence: low
Full summary, score breakdown and related studies → Original source
Considering the significant impact of dementia, the Italian Ministry of Health entrusted the Italian National Institute of Health (Istituto Superiore di Sanità) with the development of a guideline within the Italian National Guideline System (Sistema Nazionale Linee Guida, SNLG) on the diagnosis and treatment of dementia and MCI. 3 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Of the 15 articles that were included, most used qualitative methods (N = 13) and were conducted in long-term care facilities (N = 14). 1 key finding →
Participants: 13 Evidence: low
Full summary, score breakdown and related studies → Original source
The changing dynamics over a 20-year period of this palliative care programme in Kerala, India, highlights the need for similar programmes to remain flexible and adapt their services in response to a growing global burden of Non Communicable Diseases. 2 key findings →
Evidence: moderate
Full summary, score breakdown and related studies → Original source
For the 61 residents, the average age of the residents was 87 years, with 61% being female and 69% having dementia as the primary diagnosis. 3 key findings →
Participants: 61 Evidence: low
Full summary, score breakdown and related studies → Original source
Preexisting physician attitudes, knowledge, and beliefs prevent emergency physicians from addressing PC needs for AD patients. 1 key finding →
Participants: 548 Evidence: low
Full summary, score breakdown and related studies → Original source
A gap of knowledge, of information and in care intertwiningly hinder advance care planning. 2 key findings →
Participants: 15 Evidence: low
Full summary, score breakdown and related studies → Original source
Nursing home residents with dementia were more often treated without antibiotics in the Netherlands (23%) than in Missouri (15%). 3 key findings →
Participants: 706 Evidence: low
Full summary, score breakdown and related studies → Original source
Hospice offers holistic support for individuals living with terminal illness and their caregivers. 5 key findings →
Participants: 24 Evidence: low
Full summary, score breakdown and related studies → Original source
This pilot project demonstrates that a staff educational program on end-of-life care for dementia residents can improve end-of-life knowledge and attitudes among long-term care ancillary staff and that this improvement can be maintained for up to 1 year. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Virtual reality use was generally safe and enjoyable in hPLWD. 2 key findings →
Participants: 25 Evidence: low
Full summary, score breakdown and related studies → Original source
One important challenge for global development is aging. 1 key finding →
Evidence: low
Full summary, score breakdown and related studies → Original source
We found that family satisfaction with care is related to a comfort care goal shortly after admission, but quality of dying did not. 5 key findings →
Participants: 148 Evidence: low
Full summary, score breakdown and related studies → Original source
Experiences translated into four themes: acknowledging human dignity; being recognised as an important caregiver; (not) talking about death and dying and making decisions together. 5 key findings →
Participants: 32 Evidence: low
Full summary, score breakdown and related studies → Original source
Integrated Palliative care Outcome Scale for Dementia is a comprehensive and acceptable caregiver-reported measure to detect symptoms and problems in dementia. 1 key finding →
Participants: 21 Evidence: low
Full summary, score breakdown and related studies → Original source
Approximately half of the care providers evaluated both scales as being good measures of pain and easy to use. 1 key finding →
Participants: 157 Evidence: low
Full summary, score breakdown and related studies → Original source
PT assessment and utilization were uncommon in this group. 4 key findings →
Participants: 100 Evidence: low
Full summary, score breakdown and related studies → Original source
The findings identify resident subgroups at especially high risk of poor oral health who can be targeted in quality improvement efforts related to oral hygiene; they also indicate need to improve the accuracy of how MDS items are completed. 3 key findings →
Participants: 14 Evidence: low
Full summary, score breakdown and related studies → Original source
People with advanced dementia in their final phase of life have a multitude of individual and complex needs. 2 key findings →
Participants: 25 Evidence: low
Full summary, score breakdown and related studies → Original source
Free full text links and the Full text may need a subscription label come from Unpaywall, Europe PMC and OpenAlex records of free copies, checked 10 Oct 2026. A study with neither is unknown, not paywalled. Show only studies that are free to read
This is alzhub's own score. It is not an official metric, not an impact factor, and no journal, publisher or ranking body endorses it. We built it so that a reader who is not a scientist can tell a landmark trial from a conference abstract without having to already know the difference. Every point comes from one of 20 components, all of them printed on the study itself, so you can disagree with our arithmetic rather than having to trust the total.
Journals are placed in ordered tiers, never given a numeric impact factor — we could not verify current impact factors from a source we control, and an invented one would be worse than none. Tier 1 is the top-tier general journals (NEJM, The Lancet, JAMA, Nature, Science, Nature Medicine); tier 2 is the leading specialty journals; tier 3 is every other peer-reviewed journal. A separate part scores how much the journal's own papers are cited, which tells the tier-3 journals apart.
Two rules we don't bend. First, we never fill in a missing value: if a record does not state a sample size or a design, that component scores zero, and if we simply have no data for a part, such as a citation count, that part is left out and the study is scored on the parts we could check. The study card says which. Second, anything that is not a peer-reviewed article is capped at 16/100 and carries a warning chip — so a conference abstract or a company press release can never outrank a peer-reviewed paper, no matter how good it looks.
We rank a rigorous null result — a good trial showing that something does not work — above an early positive finding. Someone deciding whether to buy a supplement is served by that, and the rigour is already counted by the design and journal components.
The score is computed from the published data alone and is reproducible: the same file always yields the same numbers.
See the whole rubric drawn out → — four charts covering all 30,980 studies: how the scores are spread and where the cap bites, which of the 20 components the library is strong and weak on, which subjects rest on stronger evidence, and what kinds of study each subject is actually built from.
This is a large sample of the Alzheimer's literature, not an exhaustive index of it. It holds 30,980 records, built mostly from automated pulls of Europe PMC (65.2% of the library) and OpenAlex (16.4%), plus smaller pulls from PubMed, Crossref and medRxiv. If a study, a drug, or a finding isn't here, that is not evidence it doesn't exist in the literature — it may simply not have been pulled in yet.
1,040 records (3.4% of the library) are not peer-reviewed — 965 of those are preprints posted before any journal review, and the rest are conference abstracts, regulatory notices and reports. Every study card on this page states its status plainly, and the score above is capped for anything that isn't a peer-reviewed article.
See the full, machine-readable breakdown of this library's coverage →
Newest studies, as a dated timeline → Atom feed Where this research is being discussed: events